Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Understanding physical activity in Veterans with Parkinson disease: A mixed-methods approach.

Mantri S, Wood S, Duda JE, Morley JF.

Parkinsonism Relat Disord. 2019 Apr;61:156-160. doi: 10.1016/j.parkreldis.2018.10.023. Epub 2018 Oct 23.

PMID:
31036158
2.

The importance of preclinical diagnostics in Parkinson disease.

Mantri S, Morley JF, Siderowf AD.

Parkinsonism Relat Disord. 2018 Sep 11. pii: S1353-8020(18)30396-1. doi: 10.1016/j.parkreldis.2018.09.011. [Epub ahead of print] Review.

PMID:
30224266
3.

Physical Activity in Early Parkinson Disease.

Mantri S, Fullard ME, Duda JE, Morley JF.

J Parkinsons Dis. 2018;8(1):107-111. doi: 10.3233/JPD-171218.

4.

Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test.

Morley JF, Cohen A, Silveira-Moriyama L, Lees AJ, Williams DR, Katzenschlager R, Hawkes C, Shtraks JP, Weintraub D, Doty RL, Duda JE.

NPJ Parkinsons Dis. 2018 Jan 15;4:2. doi: 10.1038/s41531-017-0039-8. eCollection 2018.

5.

Statins and Cognition in Parkinson's Disease.

Deck BL, Rick J, Xie SX, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Trojanowski JQ, Weintraub D.

J Parkinsons Dis. 2017;7(4):661-667. doi: 10.3233/JPD-171113.

6.

Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

Fullard ME, Morley JF, Duda JE.

Neurosci Bull. 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22. Review.

7.

Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Brennan L, Devlin KM, Xie SX, Mechanic-Hamilton D, Tran B, Hurtig HH, Chen-Plotkin A, Chahine LM, Morley JF, Duda JE, Roalf DR, Dahodwala N, Rick J, Trojanowski JQ, Moberg PJ, Weintraub D.

J Parkinsons Dis. 2017;7(2):385-395. doi: 10.3233/JPD-171081.

8.

Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.

Morley JF, Cheng G, Dubroff JG, Wood S, Wilkinson JR, Duda JE.

Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.

9.

High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study.

Wilkinson JR, Spindler M, Wood SM, Marcus SC, Weintraub D, Morley JF, Stineman MG, Duda JE.

Neurol Clin Pract. 2016 Jun;6(3):241-251.

10.

Olfactory impairment predicts cognitive decline in early Parkinson's disease.

Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF.

Parkinsonism Relat Disord. 2016 Apr;25:45-51. doi: 10.1016/j.parkreldis.2016.02.013. Epub 2016 Feb 19.

11.

Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-Analysis.

Brennan L, Pantelyat A, Duda JE, Morley JF, Weintraub D, Wilkinson JR, Moberg PJ.

Mov Disord Clin Pract. 2015 Dec 7;3(2):161-167. doi: 10.1002/mdc3.12264. eCollection 2016 Mar-Apr.

12.

Longitudinal study of normal cognition in Parkinson disease.

Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D.

Neurology. 2015 Oct 13;85(15):1276-82. doi: 10.1212/WNL.0000000000002001. Epub 2015 Sep 11.

13.

Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease.

Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF.

Parkinsonism Relat Disord. 2015 Jul;21(7):723-8. doi: 10.1016/j.parkreldis.2015.04.016. Epub 2015 Apr 23.

PMID:
25940998
14.

Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking.

Sharer JD, Leon-Sarmiento FE, Morley JF, Weintraub D, Doty RL.

Mov Disord. 2015 May;30(6):859-62. doi: 10.1002/mds.26126. Epub 2014 Dec 27.

15.

Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.

Morley JF, Pawlowski SM, Kesari A, Maina I, Pantelyat A, Duda JE.

Parkinsonism Relat Disord. 2014 Jul;20(7):738-42. doi: 10.1016/j.parkreldis.2014.03.024. Epub 2014 Apr 1.

PMID:
24742370
16.

Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.

Trinh J, Amouri R, Duda JE, Morley JF, Read M, Donald A, Vilariño-Güell C, Thompson C, Szu Tu C, Gustavsson EK, Ben Sassi S, Hentati E, Zouari M, Farhat E, Nabli F, Hentati F, Farrer MJ.

Neurobiol Aging. 2014 May;35(5):1125-31. doi: 10.1016/j.neurobiolaging.2013.11.015. Epub 2013 Nov 22.

PMID:
24355527
17.

Complete and readily reversible blocking of striatal DaTscan binding by methylphenidate.

Cheng G, Morley JF.

Clin Nucl Med. 2014 Feb;39(2):211-3. doi: 10.1097/RLU.0000000000000307.

PMID:
24300364
18.

Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.

Morley JF, Duda JE.

J Parkinsons Dis. 2014;4(2):169-73. doi: 10.3233/JPD-130299. Review.

PMID:
24284418
19.

Head injury and the risk of Parkinson's disease.

Morley JF, Duda JE.

Mov Disord. 2012 Nov;27(13):1592-4. doi: 10.1002/mds.25230. No abstract available.

PMID:
23192921
20.

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.

Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW, Duda JE.

Neurology. 2012 Dec 11;79(24):2307-14. doi: 10.1212/WNL.0b013e318278fe32. Epub 2012 Nov 14.

21.

Parkinson's disease and the risk of cerebrovascular pathology.

Morley JF, Duda JE.

Mov Disord. 2012 Oct;27(12):1471-2. doi: 10.1002/mds.25179. Epub 2012 Oct 2. No abstract available.

PMID:
23033113
22.

Genetic influences on cognitive decline in Parkinson's disease.

Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A.

Mov Disord. 2012 Apr;27(4):512-8. doi: 10.1002/mds.24946. Epub 2012 Feb 16.

23.

Neuropsychological correlates of olfactory dysfunction in Parkinson's disease.

Morley JF, Duda JE.

J Neurol Sci. 2011 Nov 15;310(1-2):228-30. doi: 10.1016/j.jns.2011.05.030. Epub 2011 Jun 11. Review.

PMID:
21658728
24.

Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.

Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE.

Mov Disord. 2011 Sep;26(11):2051-7. doi: 10.1002/mds.23792. Epub 2011 May 24.

25.

Current understanding and management of Parkinson disease: five new things.

Morley JF, Hurtig HI.

Neurology. 2010 Nov 2;75(18 Suppl 1):S9-15. doi: 10.1212/WNL.0b013e3181fb3628. Review. No abstract available.

PMID:
21041778
26.

Olfaction as a biomarker in Parkinson's disease.

Morley JF, Duda JE.

Biomark Med. 2010 Oct;4(5):661-70. doi: 10.2217/bmm.10.95. Review.

PMID:
20945979
27.

The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus.

Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG.

Epilepsia. 2010 Jun;51(6):1083-5. doi: 10.1111/j.1528-1167.2009.02388.x. Epub 2009 Oct 20.

28.

Autopsy investigation of neurodegenerative disease transplant patients: hindsight is 20/20.

Morley JF, Duda JE.

Neurology. 2009 Oct 6;73(14):1086-7. doi: 10.1212/WNL.0b013e3181bc6758. Epub 2009 Sep 2. No abstract available.

PMID:
19726748
29.

Frontal encephalocele in a middle-aged woman with first seizure: smells like a seizure to me.

Morley JF, Kolson DL.

Neurology. 2008 Jan 8;70(2):157. doi: 10.1212/01.wnl.0000296822.59839.38. No abstract available.

PMID:
18180446
30.

The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging.

Brignull HR, Morley JF, Morimoto RI.

Adv Exp Med Biol. 2007;594:167-89. Review.

PMID:
17205684
31.

Modeling polyglutamine pathogenesis in C. elegans.

Brignull HR, Morley JF, Garcia SM, Morimoto RI.

Methods Enzymol. 2006;412:256-82.

PMID:
17046663
32.

Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones.

Morley JF, Morimoto RI.

Mol Biol Cell. 2004 Feb;15(2):657-64. Epub 2003 Dec 10.

33.

The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.

Morley JF, Brignull HR, Weyers JJ, Morimoto RI.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10417-22. Epub 2002 Jul 16.

Supplemental Content

Loading ...
Support Center